These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 8991806

  • 1. The alpha 1-adrenoceptor agonist, SDZ NVI-085, behaves as a potent, competitive antagonist of 5-hydroxytryptamine-induced contraction of rat aorta.
    Van der Graaf PH, Apaydin S, Saxena PR.
    Eur J Pharmacol; 1995 Dec 20; 287(3):309-12. PubMed ID: 8991806
    [Abstract] [Full Text] [Related]

  • 2. The adrenoceptor agonist, SDZ NVI 085, discriminates between alpha 1A- and alpha 1B-adrenoceptor subtypes in vas deferens, kidney and aorta of the rat.
    Eltze M, Boer R.
    Eur J Pharmacol; 1992 Dec 02; 224(2-3):125-36. PubMed ID: 1361446
    [Abstract] [Full Text] [Related]

  • 3. SDZ NVI 085, an alpha 1A-adrenoceptor agonist with 5-HT2A receptor antagonist properties.
    Lachnit WG, Ford AP, Clarke DE.
    Eur J Pharmacol; 1996 Feb 15; 297(1-2):83-6. PubMed ID: 8851170
    [Abstract] [Full Text] [Related]

  • 4. Characterization of the alpha 1-adrenoceptor subtype mediating contraction of guinea-pig spleen.
    Eltze M.
    Eur J Pharmacol; 1994 Aug 01; 260(2-3):211-20. PubMed ID: 7988645
    [Abstract] [Full Text] [Related]

  • 5. Evidence for a 5-HT1D receptor-mediated hypothermic effect of the alpha 1-adrenoceptor agonist, SDZ NVI-085, in guinea-pigs.
    Kalkman HO, Neumann V.
    Eur J Pharmacol; 1995 Oct 24; 285(3):313-5. PubMed ID: 8575520
    [Abstract] [Full Text] [Related]

  • 6. Characterization of alpha1-adrenoceptor subtypes in facilitation of rat spinal motoneuron activity.
    Wada T, Hasegawa Y, Ono H.
    Eur J Pharmacol; 1997 Dec 04; 340(1):45-52. PubMed ID: 9527505
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological activity of (-)-discretamine, a novel vascular alpha-adrenoceptor and 5-hydroxytryptamine receptor antagonist, isolated from Fissistigma glaucescens.
    Ko FN, Yu SM, Su MJ, Wu YC, Teng CM.
    Br J Pharmacol; 1993 Oct 04; 110(2):882-8. PubMed ID: 7902181
    [Abstract] [Full Text] [Related]

  • 8. Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen.
    Aboud R, Shafii M, Docherty JR.
    Br J Pharmacol; 1993 May 04; 109(1):80-7. PubMed ID: 8098642
    [Abstract] [Full Text] [Related]

  • 9. Functional evidence for an alpha 1B-adrenoceptor mediating contraction of the mouse spleen.
    Eltze M.
    Eur J Pharmacol; 1996 Sep 12; 311(2-3):187-98. PubMed ID: 8891599
    [Abstract] [Full Text] [Related]

  • 10. Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery.
    Hussain MB, Marshall I.
    Br J Pharmacol; 1997 Nov 12; 122(5):849-58. PubMed ID: 9384500
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological activity of DC-015, a novel potent and selective alpha 1-adrenoceptor antagonist.
    Yen MH, Sheu JR, Peng IH, Lee YM, Chern JW.
    J Pharm Pharmacol; 1996 Jan 12; 48(1):90-5. PubMed ID: 8722503
    [Abstract] [Full Text] [Related]

  • 12. The relationship between density of alpha-adrenoceptor binding sites and contractile responses in several porcine isolated blood vessels.
    Wright IK, Blaylock NA, Kendall DA, Wilson VG.
    Br J Pharmacol; 1995 Feb 12; 114(3):678-88. PubMed ID: 7735695
    [Abstract] [Full Text] [Related]

  • 13. Is SDZ NVI-085 an alpha 1-adrenoceptor subtype-selective agonist?
    Büscher R, Insel PA, Michel MC.
    Life Sci; 1994 Feb 12; 54(14):999-1007. PubMed ID: 7908116
    [Abstract] [Full Text] [Related]

  • 14. The pharmacology of RS-15385-197, a potent and selective alpha 2-adrenoceptor antagonist.
    Brown CM, MacKinnon AC, Redfern WS, Hicks PE, Kilpatrick AT, Small C, Ramcharan M, Clague RU, Clark RD, MacFarlane CB.
    Br J Pharmacol; 1993 Feb 12; 108(2):516-25. PubMed ID: 8095420
    [Abstract] [Full Text] [Related]

  • 15. Alpha 2-adrenoceptor blocking profile of SK&F 104078: further evidence for receptor subtypes.
    Akers I, Coates J, Drew GM, Sullivan AT.
    Br J Pharmacol; 1991 Apr 12; 102(4):943-9. PubMed ID: 1677300
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological evaluation of ocoteine, isolated from Cassytha filiformis, as an alpha 1-adrenoceptor antagonist in rat thoracic aorta.
    Chang CW, Ko FN, Su MJ, Wu YC, Teng CM.
    Jpn J Pharmacol; 1997 Mar 12; 73(3):207-14. PubMed ID: 9127815
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
    Kenny BA, Miller AM, Williamson IJ, O'Connell J, Chalmers DH, Naylor AM.
    Br J Pharmacol; 1996 Jun 12; 118(4):871-8. PubMed ID: 8799556
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological evaluation of N-methyl-actinodaphnine, a new vascular alpha-adrenoceptor antagonist, isolated from Illigera luzonensis.
    Guh JH, Ko FN, Yu SM, Wu YC, Teng CM.
    Eur J Pharmacol; 1995 Jun 06; 279(1):33-41. PubMed ID: 7556380
    [Abstract] [Full Text] [Related]

  • 19. Mediation of noradrenaline-induced contractions of rat aorta by the alpha 1B-adrenoceptor subtype.
    Testa R, Guarneri L, Poggesi E, Simonazzi I, Taddei C, Leonardi A.
    Br J Pharmacol; 1995 Feb 06; 114(4):745-50. PubMed ID: 7773533
    [Abstract] [Full Text] [Related]

  • 20. The 5-HT and alpha-adrenoceptor antagonist effect of four benzylisoquinoline alkaloids on rat aorta.
    Catret M, Ivorra MD, D'Ocón MP, Anselmi E.
    J Pharm Pharmacol; 1998 Mar 06; 50(3):317-22. PubMed ID: 9600725
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.